Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alasdair Coles

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Brain : a Journal of Neurology|June 6, 2022
Campath, clones and the cause of autoimmunityAlasdair Coles
Annals of Indian Academy of Neurology|November 6, 2015
Newer therapies for multiple sclerosisAlasdair Coles
The Lancet. Neurology|October 21, 2006
The curious incident of disability in multiple sclerosis trialsAlasdair Coles
Practical Neurology|March 18, 2009
Multiple sclerosisAlasdair Coles
The Lancet. Neurology|August 21, 2007
The fragile benefit of BENEFITAlasdair Coles
Brain : a Journal of Neurology|December 12, 2024
A blood test to predict prognosis in multiple sclerosis?Alasdair Coles
Annals of Neurology|March 9, 2018
Authorship of phase 3 trials in multiple sclerosisAlasdair Coles
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2012
We are about to cure MS in the next 10 years, even though we do not know its cause: noAlasdair Coles
The Lancet. Neurology|September 5, 2009
Trials of diminishing relapses for diminishing returnsAlasdair Coles
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 2, 2017
Physician-assisted death should be available to people with MS - CommentaryAlasdair Coles
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Brain : a Journal of Neurology|June 6, 2022
Campath, clones and the cause of autoimmunityAlasdair Coles
Annals of Indian Academy of Neurology|November 6, 2015
Newer therapies for multiple sclerosisAlasdair Coles
The Lancet. Neurology|October 21, 2006
The curious incident of disability in multiple sclerosis trialsAlasdair Coles
Practical Neurology|March 18, 2009
Multiple sclerosisAlasdair Coles
The Lancet. Neurology|August 21, 2007
The fragile benefit of BENEFITAlasdair Coles
Brain : a Journal of Neurology|December 12, 2024
A blood test to predict prognosis in multiple sclerosis?Alasdair Coles
Annals of Neurology|March 9, 2018
Authorship of phase 3 trials in multiple sclerosisAlasdair Coles
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2012
We are about to cure MS in the next 10 years, even though we do not know its cause: noAlasdair Coles
The Lancet. Neurology|September 5, 2009
Trials of diminishing relapses for diminishing returnsAlasdair Coles
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 2, 2017
Physician-assisted death should be available to people with MS - CommentaryAlasdair Coles
Pageof 8